Professional
Added to YB: 2021-04-15
Pitch date: 2021-04-15
THOR [bullish]
Synthorx, Inc.
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Synthorx, Inc., a biopharmaceutical company, focuses on the development of cytokine Synthorin programs for the treatment of cancer and autoimmune disorders in the United States.
Market Cap
$2.2B
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-27.91
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
SouthernSun Small Cap q1 2021 fund letter - Thor Industries, Inc. (THOR)
A summary for this pitch has not been created yet.
Read full article (1 min)